immunos

imbiologics

The company develops antibody therapeutics for autoimmune diseases and cancer, providing these biological medicines to pharmaceutical firms and healthcare providers.

immunique

This company develops immune therapeutics, including cell therapies and peptides, for patients with cancer and autoimmune diseases.

Immunocore

This biotechnology company develops T cell receptor immunotherapies to treat patients with cancer, infectious diseases and autoimmune conditions.

Thymmune

This biotechnology company develops scalable thymic cell therapies to restore immune function for patients with immunodeficiencies, autoimmune disorders, and transplant-related conditions.

Solu Therapeutics

This biotechnology company develops antibody-based medicines that target and eliminate disease-driving cells to treat patients with cancer and immunological disorders.

Immunohelix

Immunohelix develops immune cell-specific oligonucleotide delivery systems and therapeutics for pharmaceutical companies seeking targeted treatments for immunological diseases, infections, and cancers.

Cytos Biotechnology AG

This biopharmaceutical company develops immunotherapies and vaccines targeting chronic and infectious diseases for patients and healthcare providers.

Lead Biologics

The company develops antibody-based immunotherapies for cancer and autoimmune diseases, targeting pharmaceutical firms and research institutions for early-stage development and collaboration.